Navigation Links
Triple negative breast cancer symposium highlights current advances
Date:4/27/2012

The 5th Annual Jean Sindab Triple Negative Breast Cancer Symposium, sponsored by the Winship Cancer Institute at Emory University, provides an intimate learning environment in which the most current advances in triple-negative breast cancers (TNBC) will be explored. Nationally recognized speakers will review research, clinical experiences, and provide updates on current research in TNBC. TNBC affects young women and African American women disproportionately. TNBC has no targeted therapies and chemotherapy is effective only in a minority of cases. This symposium increases awareness of TNBC and focuses on current, ongoing research to improve outcomes for patients with this disease.

Target Audience

This live activity is designed for medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, and other healthcare providers involved with or interested in the diagnosis, treatment, and management of breast cancer.

Educational Objectives

At the conclusion of the conference, the attendees should be able to:

  • Update adjuvant and neo-adjuvant approaches for treating patients with TNBC

  • Discuss different pathologic subtypes of TNBC

  • Update novel therapeutic approaches for metastatic TNBC

  • Discuss local therapeutic approaches for TNBC

  • Discuss molecular subtyping of TNBC

  • Discuss IGF1R signaling in TNBC

  • Discuss the role of DNA repair defects in TNBC

  • Discuss issues, including fatigue, in breast cancer survivors

Core Competencies: Patient Care and Medical Knowledge

Continuing Medical Education:

The Emory University School of Medicine designates this live activity for a maximum of 7 AMA Physicians Recognition Award Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.


'/>"/>
Contact: Trish Campbell
psnicho@emory.edu
404-788-2218
Emory University
Source:Eurekalert

Page: 1

Related medicine news :

1. Breaking the backbone of triple-negative breast cancers
2. Deaths triple among football players, morning temperatures thought to play a role
3. Injuries to Pedestrians Wearing Headphones Tripled Since 2004
4. SABCS: Loss of RB in triple negative breast cancer associated with favorable clinical outcome
5. First genome sequencing clinical trial for triple negative cancer points to new treatments
6. First whole-genome sequencing clinical trials for triple-negative breast cancer presented
7. Deaths From Abuse of Painkillers Triple in a Decade: CDC
8. Cases of Legionnaires Disease Tripled in 10 Years
9. Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
10. Different subtypes of triple-negative breast cancer respond to different therapies
11. Treatment for Abuse of Anti-Anxiety Drugs Tripled Over 10 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: